These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1618556)

  • 21. Role of endothelin-converting enzyme, chymase and neutral endopeptidase in the processing of big ET-1, ET-1(1-21) and ET-1(1-31) in the trachea of allergic mice.
    De Campo BA; Goldie RG; Jeng AY; Henry PJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():353S-356S. PubMed ID: 12193121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clearance of circulating endothelin-1 by ETB receptors in rats.
    Fukuroda T; Fujikawa T; Ozaki S; Ishikawa K; Yano M; Nishikibe M
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1461-5. PubMed ID: 8147891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoradiographic localization of 125I-big endothelin-1 in rat tissues.
    Stasch JP; Steinke W; Kazda S; Neuser D
    Arzneimittelforschung; 1991 May; 41(5):478-80. PubMed ID: 1898418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary endothelin: a possible biological marker of renal damage.
    Abassi ZA; Klein H; Golomb E; Keiser HR
    Am J Hypertens; 1993 Dec; 6(12):1046-54. PubMed ID: 8136095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure.
    Abassi ZA; Kotob S; Golomb E; Pieruzzi F; Keiser HR
    Hypertension; 1995 Jun; 25(6):1178-84. PubMed ID: 7768560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacodynamic properties of SOL1: a novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme.
    Nelissen J; Lemkens P; Sann H; Bindl M; Bassissi F; Jasserand D; De Mey JG; Janssen BJ
    Life Sci; 2012 Oct; 91(13-14):587-92. PubMed ID: 22365954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelin 1 hydrolysis by rat kidney membranes.
    Yamaguchi T; Fukase M; Arao M; Sugimoto T; Chihara K
    FEBS Lett; 1992 Sep; 309(3):303-6. PubMed ID: 1516701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
    Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
    Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11.
    Trapani AJ; De Lombaert S; Kuzmich S; Jeng AY
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S69-71. PubMed ID: 8587471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake and metabolism of endothelin in the isolated perfused rat lung.
    Westcott JY; Henson J; McMurtry IF; O'Brien RF
    Exp Lung Res; 1990; 16(5):521-32. PubMed ID: 2226358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme.
    De Lombaert S; Ghai RD; Jeng AY; Trapani AJ; Webb RL
    Biochem Biophys Res Commun; 1994 Oct; 204(1):407-12. PubMed ID: 7945387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats.
    Scott JM; Barclay PL; Shepperson NB
    Eur J Pharmacol; 1993 Sep; 242(1):91-7. PubMed ID: 8223941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natriuretic and renoprotective effect of chronic oral neutral endopeptidase inhibition in acute renal failure.
    Newaz M; Yousefipour Z; Oyekan A
    Ren Fail; 2010 Jan; 32(3):384-90. PubMed ID: 20370457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number.
    Brooks DP; Ohlstein EH; Contino LC; Storer B; Pullen M; Caltabiano M; Nambi P
    Eur J Pharmacol; 1991 Feb; 194(1):115-7. PubMed ID: 1647960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute increases of renal medullary osmolality stimulate endothelin release from the kidney.
    Boesen EI; Pollock DM
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F185-91. PubMed ID: 16912066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.
    Valentin JP; Qiu C; Wiedemann E; Gardner DG; Humphreys MH
    J Pharmacol Exp Ther; 1995 May; 273(2):744-52. PubMed ID: 7752077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelin and neutral endopeptidase in the endometrium of women with menorrhagia.
    Marsh MM; Malakooti N; Taylor NH; Findlay JK; Salamonsen LA
    Hum Reprod; 1997 Sep; 12(9):2036-40. PubMed ID: 9363725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The renal endothelin system in the Prague hypertensive rat, a new model of spontaneous hypertension.
    Vogel V; Bäcker A; Heller J; Kramer HJ
    Clin Sci (Lond); 1999 Jul; 97(1):91-8. PubMed ID: 10369799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.